John J Orloff - Net Worth and Insider Trading
John J Orloff Net Worth
The estimated net worth of John J Orloff is at least $6 Million dollars as of 2024-11-08. John J Orloff is the EVP, Research & Development of Alexion Pharmaceuticals Inc and owns about 31,790 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $6 Million. Details can be seen in John J Orloff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John J Orloff has not made any transactions after 2018-06-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John J Orloff
John J Orloff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John J Orloff owns 4 companies in total, including Alexion Pharmaceuticals Inc (ALXN) , Novelion Therapeutics Inc (NVLNF) , and Aegerion Pharmaceuticals Inc (AEGR) among others .
Click here to see the complete history of John J Orloff’s form 4 insider trades.
Insider Ownership Summary of John J Orloff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2020-06-08 | EVP & Research & Development |
| NVLNF | Novelion Therapeutics Inc | 2018-08-09 | director |
| AEGR | Aegerion Pharmaceuticals Inc | 2016-11-01 | EVP & Research and Development |
 | | 2016-06-03 | See Remarks |
John J Orloff Latest Holdings Summary
John J Orloff currently owns a total of 1 stock. John J Orloff owns 31,790 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 8, 2018, with a value of $6 Million.
Latest Holdings of John J Orloff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2018-06-08 | 31,790 | 182.50 | 5,801,675 |
Holding Weightings of John J Orloff
John J Orloff Form 4 Trading Tracker
According to the SEC Form 4 filings, John J Orloff has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 2,115 shares on June 8, 2018, which brought John J Orloff around $250,691.
Insider Trading History of John J Orloff
- 1
John J Orloff Trading Performance
John J Orloff Ownership Network
Ownership Network List of John J Orloff
Ownership Network Relation of John J Orloff
John J Orloff Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
John J Orloff is the EVP & Research & Development of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
John J Orloff Mailing Address
Above is the net worth, insider trading, and ownership report for John J Orloff. You might contact John J Orloff via mailing address: C/o Baxalta Incorporated 1200 Lakeside Drive Bannockburn Il 60015.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
